Views and opinions of patients with glaucoma and age-related macular degeneration on vision home-monitoring: a UK-based focus group study
Dave, S. ORCID: 0000-0002-2420-3991, Rathore, M. ORCID: 0000-0001-5749-2761, Campbell, P. ORCID: 0000-0002-6019-1596 , Edgar, D. F. ORCID: 0000-0001-9004-264X, Crabb, D. P. ORCID: 0000-0001-8754-3902, Callaghan, T. ORCID: 0000-0002-9258-8504 & Jones, P. R. ORCID: 0000-0001-7672-8397 (2024). Views and opinions of patients with glaucoma and age-related macular degeneration on vision home-monitoring: a UK-based focus group study. BMJ Open, 14(7), article number e080619. doi: 10.1136/bmjopen-2023-080619
Abstract
Objective
To investigate the views, hopes and concerns of patients living with glaucoma and age-related macular degeneration (AMD) regarding vision home-monitoring.
Design
Qualitative study using focus groups and questionnaires. Participants were given three disease-relevant home-monitoring tests to try. The tests consisted of three visual field tests for the glaucoma groups (Melbourne Rapid Fields, Eyecatcher, Visual Fields Fast) and three acuity and/or contrast-sensitivity tests for AMD groups (Alleye, PopCSF, SpotChecks). Focus group data were thematically analysed.
Setting
University meeting rooms in London, UK.
Participants
Eight people with glaucoma (five women, median age 74) and seven people with AMD (four women, median age 77) volunteered through two UK-based charities. Participants were excluded if they did not self-report a diagnosis of glaucoma or AMD or if they lived further than a 1-hour travel distance from the university (to ensure minimal travel burden on participants).
Results
Six themes emerged from focus groups, the two most frequently referenced being: ‘concerns about home-monitoring’ and ‘patient and practitioner access to results’. Overall, participants believed home-monitoring could provide patients with a greater sense of control, but also expressed concerns, including: the possibility of home-monitoring replacing face-to-face appointments; the burden placed on clinicians by the need to process additional data; struggles to keep up with requisite technologies; and potential anxiety from seeing worrying results. Most devices were scored highly for usability, though several practical improvements were suggested.
Conclusion
Patients with mild-to-moderate glaucoma/AMD expect vision home-monitoring to be beneficial, but have significant concerns about its potential implementation.
Publication Type: | Article |
---|---|
Additional Information: | This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
Subjects: | R Medicine > RE Ophthalmology |
Departments: | School of Health & Psychological Sciences School of Health & Psychological Sciences > Optometry & Visual Sciences |
SWORD Depositor: |
Available under License Creative Commons Attribution.
Download (1MB) | Preview
Export
Downloads
Downloads per month over past year